Abstract
Kefiran is a major component of kefir which is a microbial symbiont mixture that produces jelly-like grains. This study aimed to evaluate the therapeutic availability of kefiran on the ovalbumin-induced asthma mouse model in which airway inflammation and airway hyper-responsiveness were found in the lung. BALB/c mice sensitized and challenged to ovalbumin were treated intra-gastrically with kefiran 1 hour before the ovalbumin challenge. Kefiran significantly suppressed ovalbumin-induced airway hyper-responsiveness (AHR) to inhaled methacholine. Administration of kefiran significantly inhibited the release of both eosinophils and other inflammatory cells into bronchoalveolar lavage (BAL) fluid and lung tissue which was measured by Diff-Quik. Interleukin-4 (IL-4) and interleukin-5 (IL-5) were also reduced to normal levels after administration of kefiran in BAL fluid. Histological studies demonstrate that kefiran substantially inhibited ovalbumin-induced eosinophilia in lung tissue by H&E staining and goblet cell hyperplasia in the airway by PAS staining. Taken above data, kefiran may be useful for the treatment of inflammation of lung tissue and airway hyper-responsiveness in a murine model and may have therapeutic potential for the treatment of allergic bronchial asthma.
Similar content being viewed by others
Abbreviations
- OVA:
-
ovalbumin
- BALF:
-
broncho-alveolar lavage fluid
- AHR:
-
airway hyper-responsiveness
- H&E:
-
hematoxylin and eosin
- PAS:
-
Periodic acid-Schiff
- Dex:
-
Dexamethasone
- PBS:
-
phosphate buffered saline
- ipNeb:
-
intra-peritoneal administration and nebulization
- Th2:
-
type 2 helper T cell
References
Bochner, B. S., Undem, B. J., and Lichtenstein, L. M., Immunological aspects of allergic asthma. Ann. Rev. Immuno., 12, 295–335 (1994).
Bousquet, J., Chanez, P., Lacoste, J. Y., Barnéon, G., Ghavanian, N., Enander, I., Venge, P., Ahlstedt, S., Simony-Lafontaine, J., Godard, P. et al., Eosinophilic inflammation in asthma. N. Engl. J. Med., 323, 1033–1039 (1990).
Brusselle, G. G., Kips, J. C., Tavernier, J. H., van der Heyden, J. G., Cuvelier, C. A., Pauwels, R. A., and Bluethmann, H., Attenuation of allergic airway inflammation in IL-4 deficient mice. Clin. Exp. Allergy, 24, 73–80 (1994).
Cobb, B. A. and Kasper, D. L., Coming of age: carbohydrates and immunity. Eur. J. Immunol., 35, 352–356 (2005).
Cohn, L., Homer, R. J., Marinov, A., Rankin, J., and Bottomly, K., Induction of airway mucus production By T helper 2 (Th2) cells: a critical role for interleukin 4 in cell recruitment but not mucus production. J. Exp. Med., 186, 1737–1747 (1997).
Daigle, I. and Simon, H. U., Alternative functions for TRAIL receptors in eosinophils and neutrophils. Swiss Med. Wkly., 131, 231–237 (2001).
Djukanovic, R., Roche, W. R., Wilson, J. W., Beasley, C. R., Twentyman, O. P., Howarth, R. H., and Holgate, S. T., Mucosal inflammation in asthma. Am. Rev. Respir. Dis., 142, 434–457 (1990).
Farnworth, E. R. and Mainville, I., eds, Kefir: a fermented milk product. Handbook of Fermented Functional Foods. CRC Press, 77–112 (2003).
Gonzalo, J. A., Lloyd, C. M., Kremer, L., Finger, E., Martinez-A, C., Siegelman, M. H., Cybulsky, M., and Gutierrez-Ramos, J. C., Eosinophil recruitment to the lung in a murine model of allergic inflammation. The role of T cells, chemokines, and adhesion receptors. J. Clin. Invest., 98, 2332–2345 (1996).
Hamelmann, E., Schwarze, J., Takeda, K., Oshiba, A., Larsen, G. L., Irvin, C. G., and Gelfand, E. W., Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am. J. Respir. Crit. Care Med., 156, 766–775 (1997).
Hogan, S. P., Mould, A., Kikutani, H., Ramsay, A. J., and Foster, P. S., Aeroallergen-induced eosinophilic inflammation, lung damage, and airways hyperreactivity in mice can occur independently of IL-4 and allergen-specific immunoglobulins. J. Clin. Invest., 99, 1329–1339 (1997).
Holgate, S. T., Peters-Golden, M., Panettieri, R. A., and Henderson, W. R. Jr., Roles of cysteinyl leukotrienes in airway inflammation, smooth muscle function, and remodeling. J. Allergy Clin. Immunol., 111, S18–34; discussion S34–36 (2003).
Hoshino, M., Nakamura, Y., Sim, J., Shimojo, J., and Isogai, S., Bronchial subepithelial fibrosis and expression of matrix metalloproteinase-9 in asthmatic airway inflammation. J. Allergy Clin. Immunol., 102, 783–788 (1998).
Kon, O. M., Sihra, B. S., Compton, C. H., Leonard, T. B., Kay, A. B., and Barnes, N. C., Randomised, dose-ranging, placebo-controlled study of chimeric antibody to CD4 (keliximab) in chronic severe asthma. Lancet, 352, 1109–1113 (1998).
Kumar, R. K. and Foster, P. S., Modeling allergic asthma in mice: pitfalls and opportunities. Am. J. Respir. Cell Mol. Biol., 27, 267–272 (2002).
Jeffery, P. and Zhu, J., Mucin-producing elements and inflammatory cells. Novartis Found Symp., 248, 51–68; discussion 68–75, 277–282 (2002).
La Riviere, J. W. and Kooiman, P., Kefiran, a novel polysaccharide produced in the kefir grain by Lactobacillus brevis. Arch. Microbiol., 59, 269–278 (1967).
Lee, J. J., McGarry, M. P., Farmer, S. C., Denzler, K. L., Larson, K. A., Carrigan, P. E., Brenneise, I. E., Horton, M. A., Haczku, A., Gelfand, E. W., Leikauf, G. D., and Lee, N. A., Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma. J. Exp. Med., 185, 2143–2156 (1997).
Lee, M. Y., Ahn, K. S., Kwon, O. K., Kim, M. J., Kim, M. K., Lee, I. Y., Oh, S. R., and Lee, H. K., Anti-inflammatory and anti-allergic effects of kefir in a mouse asthma model. Immunobiology., 212, 647–654 (2007).
Nakajima, H., Iwamoto, I., Tomoe, S., Matsumura, R., Tomioka, H., Takatsu, K., and Yoshida, S., CD4+ T-lymphocytes and interleukin-5 mediate antigen-induced eosinophil infiltration into the murine trachea. Am. Rev. Respir. Dis., 146, 374–377 (1992).
Nakata, J., Kondo, M., Tamaoki, J., Takemiya, T., Nohara, M., Yamagata, K., and Nagai, A., Augmentation of allergic inflammation in the airways of cyclooxygenase-2-deficient mice. Respirology, 10, 149–156 (2005)
Micheli, L., Uccelletti, D., Palleschi, C., and Crescenzi, V., Isolation and characterisation of a ropy Lactobacillus strain producing the exopolysaccharide kefiran. Appl. Microbiol. Biotechnol., 53, 69–74 (1999)
Rankin, J. A., Picarella, D. E., Geba, G. P., Temann, U. A., Prasad, B., DiCosmo, B., Tarallo, A., Stripp, B., Whitsett, J., and Flavell, R. A., Phenotypic and physiologic characterization of transgenic mice expressing interleukin 4 in the lung: lymphocytic and eosinophilic inflammation without airway hyperreactivity. Proc. Natl. Acad. Sci. U S A, 93, 7821–7825 (1996).
Robinson, D. S., Hamid, Q., Ying, S., Tsicopoulos, A., Barkans, J., Bentley, A. M., Corrigan, C., Durham, S. R., and Kay, A. B., Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N. Engl. J. Med., 326, 298–304 (1992).
Robinson, D. S., Durham, S. R., and Kay, A. B., Cytokines. 3. Cytokines in asthma. Thorax, 48, 845–853 (1993).
Rogers, L., Cassino, C., Berger, K. I., Goldring, R. M., Norman, R. G., Klugh, T., and Reibman, J., Asthma in the elderly: cockroach sensitization and severity of airway obstruction in elderly nonsmokers. Chest, 122, 1580–1586 (2002).
Saloff-Coaste, C., Kefir, Danonne Newsletter, 1–11 (1996).
Sampson, A. P., The leukotrienes: mediators of chronic inflammation in asthma. Clin. Exp. Allergy, 26, 995–1004 (1996).
Vinderola, C. G., Medici, M., and Perdigón, G., Relationship between interaction sites in the gut, hydrophobicity, mucosal immunomodulating capacities and cell wall protein profiles in indigenous and exogenous bacteria. J. Appl. Microbiol., 96, 230–243 (2004).
Vinderola, C. G., Duarte, J., Thangavel, D., Perdigón, G., Farnworth, E., and Matar, C., Immunomodulating capacity of kefir. J. Dairy Res., 72, 195–202 (2005).
Vinderola, G., Perdigón, G., Duarte, J., Farnworth, E., and Matar, C., Effects of the oral administration of the exopolysaccharide produced by Lactobacillus kefiranofaciens on the gut mucosal immunity. Cytokine, 36, 254–260 (2006).
Walker, C., Kaegi, M. K., Braun, P., and blasér, K., Activated T cells and eosinophilia in bronchoalveolar lavages from subjects with asthma correlated with disease severity. J. Allergy Clin. Immunol., 88, 935–942 (1991).
Wardlaw, A. J., Molecular basis for selective eosinophil trafficking in asthma: A multistep paradigm. J. Allergy Clin. Immunol., 104, 917–926 (1999).
Wood, L. G., Gibson, P. G., and Garg, M. L., Biomarkers of lipid peroxidation, airway inflammation and asthma. Eur. Respir. J., 21, 177–186 (2003)
Author information
Authors and Affiliations
Corresponding author
Additional information
These two authors made equal contribution to this work.
Rights and permissions
About this article
Cite this article
Kwon, OK., Ahn, KS., Lee, MY. et al. Inhibitory effect of kefiran on ovalbumin-induced lung inflammation in a murine model of asthma. Arch. Pharm. Res. 31, 1590–1596 (2008). https://doi.org/10.1007/s12272-001-2156-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-001-2156-4